Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-179

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 25021-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dap04 0018 02

Daptomycin 350 mg per vial injection powder label for intravenous use by Sagent Pharmaceuticals. The label indicates refrigeration requirement, single-dose vial status, and reconstitution instructions. The label includes the NDC 25021-179-15 and storage conditions between 2°C and 8°C. Barcodes and manufacturer details are also visible.*

FDA Label Image

Dap04 0019 01

Chemical structure diagram of Daptomycin, showing the molecular framework and peptide bonds of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.